BAGNEUX, France--(BUSINESS WIRE)--Genomic Vision (Paris:GV) a French molecular diagnostics company specializing in the development of diagnostic tests for genetic diseases and cancers based on molecular combing technology, announces that Company management will participate at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum taking place on November 19th at the Westin Grand Central Hotel in New York City. Aaron Bensimon, Ph.D., CEO & President of Genomic Vision, will deliver the Company’s corporate presentation on Thursday, November 19th at 11:40 a.m. Eastern Time (5:40 p.m. CET).
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
